Sciex acquires Intabio

By The Science Advisory Board staff writers

January 22, 2021 -- Sciex has acquired Intabio, developer of the Blaze system for biotherapeutic analysis and quality assessment. The Blaze system enables direct coupling of imaged capillary isoelectric focusing for charge variant analysis with high-resolution mass spectrometry to detect intact proteins.

The innovative technology provides a solution for the company's customers who are looking for better and faster tools to characterize their complex biomolecules. The combined Blaze system plus mass spectrometry approach is streamlined to reduce sample preparation times and increases sample throughput.

Intabio employees and products will transition into Sciex while continuing to operate from its existing facilities in Fremont, CA. Financial terms of the transaction were not disclosed.

Sciex, 908 Devices launch biotherapeutics characterization platform
Sciex and 908 Devices have made the ZipChip platform for Sciex mass spectrometers available to the public. This platform expands mass spectrometers from...

Copyright © 2021

BioTech Pharma Summit
September 27-28
Porto Portugal
Infectious Diseases (ID) Week 2021
September 29 - October 3
San Diego, California United States
Imaging Mass Spectrometry Society (IMSS) 3 in 2021
October 3-6
Colorado Springs, Colorado United States
Cell & Gene Meeting on the Mesa
October 10-14
Carlsbad, California United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter